Proteomics for the investigation of acute kidney injury

Prasad Devarajan1

  • 1Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.

Insights

New biomarkers for acute kidney injury (AKI) are emerging from proteomics research. These novel markers show promise for early detection, prognosis, and understanding AKI causes.

Area of Science:

  • Biochemistry
  • Nephrology
  • Molecular Biology

Background:

  • Acute kidney injury (AKI), also known as acute renal failure (ARF), is a significant clinical problem with high mortality and morbidity.
  • Current challenges in managing AKI include a limited understanding of its pathophysiology and a lack of early diagnostic markers, leading to delayed treatment.
  • Innovative technologies like functional genomics and proteomics are uncovering new therapeutic targets and biomarkers for AKI.

Purpose of the Study:

  • To review recent advances in proteomics for identifying biomarkers in ischemic AKI, a common and severe subtype of ARF.
  • To highlight novel protein biomarkers discovered in plasma and urine for AKI investigation.
  • To discuss the potential of these biomarkers in assessing AKI timing, duration, etiology, and clinical outcomes.

Main Methods:

  • Review of recent scientific literature focusing on proteomics and biomarker discovery in AKI.
  • Analysis of studies identifying novel genes and proteins in human and animal models of AKI.
  • Compilation of identified plasma and urine biomarkers, including NGAL, cystatin C, KIM-1, IL-18, alpha 1-microglobulin, fetuin-A, Gro-alpha, and meprin.

Main Results:

  • Identification of several promising protein biomarkers in plasma (e.g., NGAL, cystatin C) and urine (e.g., NGAL, KIM-1, IL-18, cystatin C, alpha 1-microglobulin, fetuin-A, Gro-alpha, meprin) for AKI.
  • Emerging evidence suggests these biomarkers can aid in determining the timing and duration of AKI.
  • Differential expression patterns of biomarkers may help distinguish between various causes of AKI and predict patient outcomes.

Conclusions:

  • Proteomics has uncovered novel biomarkers with significant potential for improving AKI diagnosis and management.
  • These biomarkers may enable earlier detection, better characterization of AKI, and prediction of clinical outcomes.
  • Further research and clinical validation are essential to fully integrate these proteomic discoveries into routine AKI care.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...